Targeted therapy tested in dermatomyositis - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Targeted therapy tested in dermatomyositis

Researchers found higher composite improvement scores and greater glucocorticoid tapering with the 30‐mg dose, though serious infections were more frequent.

  • By

  • Kathryn Wighton

  • August 20, 2026

  • 4 min

Share

Original Source(s)

Targeted therapy tested in dermatomyositis

  • by Kathryn Wighton

  • August 20, 2026

Related Content

Parallel Ridge Pattern Signals Acral Melanoma Risk

Meta-analysis supports multi-feature dermoscopic evaluation.

Dupilumab Faces Trial in Chronic Hives

Phase III CUPID-C trial evaluates biologic therapy in patients with chronic spontaneous urticaria uncontrolled by antihistamines.

ALK-positive Spitz nevus of the nasal dorsum in a child: a case report and literature review